Up Next
Back to Show
PBS News Hour
Why FDA approval of sickle cell gene therapy is a ‘big deal’
Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Support Provided By
Season
57:46
November 14, 2024 - PBS News Hour full episode
57:46
November 13, 2024 - PBS News Hour full episode
57:46
November 12, 2024 - PBS News Hour full episode
57:46
November 11, 2024 - PBS News Hour full episode
26:45
November 10, 2024 - PBS News Weekend full episode
26:45
November 9, 2024 - PBS News Weekend full episode
57:46
November 8, 2024 - PBS News Hour full episode
57:46
November 7, 2024 - PBS News Hour full episode
57:46
November 6, 2024 - PBS News Hour full episode
56:58
November 5, 2024 - PBS News Hour full episode
57:46
November 4, 2024 - PBS News Hour full episode
26:44
November 3, 2024 - PBS News Weekend full episode